Long-Term Follow-Up of the TRED-HF Trial: Implications for Therapy in Patients with Dilated Cardiomyopathy and Heart Failure Remission
The risk of relapse in the 5 years following the TRED-HF trial remained high. Restarting lower doses of heart failure medications at the end of the trial, external triggers and disease progression are likely to have contributed to relapse.
Authors
- A. John Baksi
- Amrit Lota (ORCID: https://orcid.org/0000-0001-5653-8211)
- Daniel Hammersley (ORCID: https://orcid.org/0000-0002-1164-5993)
- Aaraby Ragavan
- John G.F. Cleland (ORCID: https://orcid.org/0000-0002-1471-7016)
- James S. Ware (ORCID: https://orcid.org/0000-0002-6110-5880)
- John Gregson (ORCID: https://orcid.org/0000-0001-6084-166X)
- L Cheng (ORCID: https://orcid.org/0009-0006-9996-7116)
- Srinjay Mukhopadhyay (ORCID: https://orcid.org/0000-0003-4419-8808)
- Jennie Han (ORCID: https://orcid.org/0000-0002-5655-5406)
- Brian P. Halliday (ORCID: https://orcid.org/0000-0002-5876-1748)
- Upasana Tayal (ORCID: https://orcid.org/0000-0003-2262-4626)
- Zohya Khalique (ORCID: https://orcid.org/0000-0002-0977-4796)
- Antonio de Marvao (ORCID: https://orcid.org/0000-0001-9095-5887)
- Dudley J. Pennell (ORCID: https://orcid.org/0000-0001-5523-1314)
- Saad Javed (ORCID: https://orcid.org/0000-0002-8039-0373)
- Sanjay Prasad (ORCID: https://orcid.org/0000-0002-5637-0727)
- Antonis Pantazis
- Gerald Carr‐White
Institutions
- King's College London (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Royal Brompton & Harefield NHS Foundation Trust (GB)
- Harefield Hospital (GB)
- British Heart Foundation (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Royal Brompton Hospital (GB)
- Lung Institute (US)
- Thomas Foundation (AU)
- MRC London Institute of Medical Sciences (GB)
- Imperial College London (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1002/ejhf.3475
- Citations
- 15
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.03
Funders
- Israel Cancer Research Fund
- Wellcome Trust
- National Institute for Health and Care Research
- British Heart Foundation
- Imperial College London
- Rosetrees Trust